Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Pharmagap Inc. (GAP)

Pharmagap Inc.
Date:
Sort by:
 Showing the most relevant articles for your search:TSXV:GAP
DateTimeSourceHeadlineSymbolCompany
07/05/201315:26PR Newswire (Canada)PharmaGap Notified of Cease Trade OrderTSXV:GAPPharmagap Inc.
06/05/201319:47PR Newswire (Canada)TSX Venture Exchange Cease Trade OrderTSXV:GAPPharmagap Inc.
06/05/201313:20PR Newswire (Canada)IIROC Trading Halt - GAPTSXV:GAPPharmagap Inc.
06/05/201313:20PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - GAPTSXV:GAPPharmagap Inc.
06/02/201313:00PR Newswire (Canada)PharmaGap Receives Notice of Pending Transfer to NEX ExchangeTSXV:GAPPharmagap Inc.
04/02/201316:11PR Newswire (Canada)L’OCRCVM permet la reprise de la négociation - GAPTSXV:GAPPharmagap Inc.
04/02/201316:11PR Newswire (Canada)IIROC Trading Resumption - GAPTSXV:GAPPharmagap Inc.
04/02/201315:32PR Newswire (Canada)PharmaGap Provides Update on StatusTSXV:GAPPharmagap Inc.
04/02/201314:11PR Newswire (Canada)IIROC Trading Halt - GAPTSXV:GAPPharmagap Inc.
04/02/201314:11PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - GAPTSXV:GAPPharmagap Inc.
02/08/201212:03PR Newswire (Canada)PharmaGap Shareholders Approve License to Clinical Value Corporation at Annual General MeetingTSXV:GAPPharmagap Inc.
05/07/201213:00PR Newswire (Canada)PharmaGap Receives Independent Value Opinion and Support of Independent Committee for Proposed License to Clinical Value CorporTSXV:GAPPharmagap Inc.
05/06/201213:30PR Newswire (Canada)PharmaGap Updates Lead Drug Status and Potential SaleTSXV:GAPPharmagap Inc.
24/05/201213:30PR Newswire (Canada)PharmaGap announces conditional approval to license its lead drug and related intellectual propertyTSXV:GAPPharmagap Inc.
20/01/201220:19Marketwired CanadaPharmaGap Completes $231,000 Private PlacementTSXV:GAPPharmagap Inc.
11/01/201220:21Marketwired CanadaPharmaGap Completes $70,774 Private PlacementTSXV:GAPPharmagap Inc.
21/12/201112:00Marketwired CanadaPharmaGap Completes In Vivo Study Protocol in Ovarian CancerTSXV:GAPPharmagap Inc.
05/12/201112:00Marketwired CanadaPharmaGap Completes $634,210 Private PlacementTSXV:GAPPharmagap Inc.
28/11/201120:48MarketwiredPharmaGap Completes Initial Closing of Private PlacementTSXV:GAPPharmagap Inc.
25/11/201113:00MarketwiredPharmaGap Liposomal Formulations Achieve Key Milestones for Clinical TrialsTSXV:GAPPharmagap Inc.
15/11/201113:00MarketwiredPharmaGap Announces Start of Definitive Animal Efficacy Study Required to Proceed to Clinical TrialsTSXV:GAPPharmagap Inc.
27/10/201113:00MarketwiredPharmaGap Sets Time for in Vivo TestsTSXV:GAPPharmagap Inc.
24/10/201113:00MarketwiredPharmaGap Chooses Ovarian Cancer as Target for First Clinical TrialsTSXV:GAPPharmagap Inc.
21/10/201121:00MarketwiredPharmaGap Completes Placement of Equity UnitsTSXV:GAPPharmagap Inc.
21/10/201121:00Marketwired CanadaPharmaGap Completes Placement of Equity UnitsTSXV:GAPPharmagap Inc.
19/10/201113:00MarketwiredPharmaGap Completes Manufacturer Site Audits Required for Clinical Trial SubmissionTSXV:GAPPharmagap Inc.
03/10/201113:38MarketwiredPharmaGap Files Provisional Patent Application for Liposomal Formulations of GAP-107B8TSXV:GAPPharmagap Inc.
30/09/201115:00MarketwiredPharmaGap to Host Investor Conference CallTSXV:GAPPharmagap Inc.
29/09/201113:43MarketwiredPharmaGap Adds to Patent Portfolio For GAP-107B8 Cancer Drug; Expands ClaimsTSXV:GAPPharmagap Inc.
22/09/201113:44MarketwiredPharmaGap Completes Initial Close of Private PlacementTSXV:GAPPharmagap Inc.
 Showing the most relevant articles for your search:TSXV:GAP